Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
0.310
-0.007 (-2.11%)
Feb 21, 2025, 4:00 PM EST - Market closed
Venus Concept Employees
Venus Concept had 304 employees as of December 31, 2023. The number of employees decreased by 80 or -20.83% compared to the previous year.
Employees
304
Change (1Y)
-80
Growth (1Y)
-20.83%
Revenue / Employee
$221,053
Profits / Employee
-$164,957
Market Cap
2.25M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
VERO News
- 3 months ago - Venus Concept Inc. (VERO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India - GlobeNewsWire
- 5 months ago - Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024 - GlobeNewsWire
- 5 months ago - Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction - GlobeNewsWire
- 5 months ago - Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX - GlobeNewsWire
- 6 months ago - Venus Concept Inc. (VERO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Venus Concept Announces Second Quarter of Fiscal Year 2024 Financial Results - GlobeNewsWire